STN: BL 125127 Proper Name: Influenza Vaccine Tradename: FLUARIX Manufacturer: GlaxoSmithKline Biologicals Indication: For active immunization for the prevention of disease caused by influenza A ...

FLUARIX QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

FLUARIX and FLULAVAL are vaccines indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccines. FLUARIX and FLULAVAL are approved for use in persons aged 6 months and older.

Jul 16, 2023 · Fluarix Quadrivalent package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Aug 15, 2023 · Fluarix Quadrivalent is a vaccine used prevent infection caused by influenza. Learn about side effects, interactions and indications.

Jul 14, 2021 · FLUARIX® QUADRIVALENT is indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine [see DESCRIPTION]. FLUARIX QUADRIVALENT is approved for use in persons aged 3 years and older. Dosage for Fluarix. For intramuscular injection only. Dosage And Schedule

The only SAEs reported in more than a single subject in either vaccine arm were pneumonia (3 Fluarix subjects and 2 Fluzone subjects), lymphadenitis (2 Fluarix subjects and none in Fluzone...

Find patient medical information for Fluarix Quad 2020-2021 (PF) intramuscular on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Jul 9, 2024 · Fluarix package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Aug 29, 2024 · For 2024–25, this category is expected to include five different vaccines (Table 1). Four of these are egg-based vaccines (Afluria, Fluarix, FluLaval, and Fluzone), and one is a cell culture–based vaccine (Flucelvax [ccIIV3]). All are approved for persons aged ≥6 months.